Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Yabao Pharmaceutical Co. Inc.

www.yabao.com.cn

Latest From Yabao Pharmaceutical Co. Inc.

Asia Executives To Watch: Alcon Japan New President, AZ International EVP

Autumn has brought a flurry of personnel changes with Kyowa FujiFilm getting a new president and AZ a new executive vice president for the international region. Fosun and the medtech firm, Median Technologies, have also seen personnel movement.

Asia Pacific Appointments

Asia Executives To Watch: Alcon Japan New President, AZ International EVP

Autumn has brought a flurry of personnel changes with Kyowa FujiFilm getting a new president and AZ a new executive vice president for the international region. Fosun and the medtech firm, Median Technologies, have also seen personnel movement.

Asia Pacific Appointments

China FDA Video Showcasing ‘Hard Work’ Grips Social Media

The China FDA has responded to doubts about its ability to meet a ticking deadline to eliminate its notorious drug approval lag with a video, which has gone viral and become an instant hit on China social media site Wechat.

Regulation China

Latest R&D Deal Builds China Antibody Interest, Expertise

To promote both the development of innovative therapeutic antibodies from research originating in China and technology transfer, the Institute Pasteur of Shanghai and MRC Technology are collaborating to speed antibody R&D and scouting licensing opportunities with local pharmas, adding to a string of deals indicative of China’s increasing expertise and interest in the sector.

BioPharmaceutical Asia Pacific
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
  • Pharmaceuticals
    • Drug Delivery
    • Generic Drugs
  • Therapeutic Areas
  • Cancer
  • Cardiovascular
  • Gynecological, Urological
  • Inflammation
  • Metabolic Disorders
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Asia
      • China
  • Parent & Subsidiaries
  • Yabao Pharmaceutical Co. Inc.
  • Senior Management
  • Peng Wang, PhD, Pres., R&D
    Luo Shizhong, Head, Partnering
  • Contact Info
  • Yabao Pharmaceutical Co. Inc.
    Phone: 10-58561099
    1 Guoying Bldg., Nan Xiao St., Xizhimen
    9th Fl.
    Xicheng District, Beijing, 100035
    China
UsernamePublicRestriction

Register